Black Diamond Therapeutics, Inc.
BDTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $118 | $124 | $65 | $193 |
| - Cash | $36 | $56 | $34 | $66 |
| + Debt | $22 | $25 | $28 | $28 |
| Enterprise Value | $104 | $93 | $59 | $156 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$78 | -$86 | -$92 | -$127 |
| % Margin | – | – | – | – |
| Net Income | -$70 | -$82 | -$91 | -$126 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.27 | -1.88 | -2.52 | -3.47 |
| % Growth | 32.4% | 25.4% | 27.4% | – |
| Operating Cash Flow | -$62 | -$67 | -$85 | -$100 |
| Capital Expenditures | $0 | -$0 | -$0 | -$3 |
| Free Cash Flow | -$62 | -$67 | -$85 | -$103 |